The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Butchofsky Robert since 2005.
The trader's CIK number is 1309652.
At the time of the last reporting, Butchofsky Robert was the President and CEO of Novelion Therapeutics Inc.. (stock ticker symbol NVLNF).
Also see all insider trading activities at Novelion Therapeutics Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2010 | QLTI | 8,000 | $45,595 | 0 | $0 | 0 | $0 |
| 2009 | QLTI | 70,000 | $144,990 | 0 | $0 | 0 | $0 |
| 2008 | QLTI | 15,000 | $36,300 | 0 | $0 | 0 | $0 |
| 2007 | QLTI | 49,847 | $256,339 | 0 | $0 | 0 | $0 |
| 2006 | QLTI | 13,500 | $98,685 | 0 | $0 | 0 | $0 |
| 2005 | QLTI | 0 | $0 | 14,200 | $123,298 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2010-11-05 | QLTI | Buy | 3,000 | 5.62 | 16,845 |
| 2010-06-21 | QLTI | Buy | 5,000 | 5.75 | 28,750 |
| 2009-11-03 | QLTI | Buy | 10,000 | 3.40 | 33,990 |
| 2009-02-20 | QLTI | Buy | 60,000 | 1.85 | 111,000 |
| 2008-10-30 | QLTI | Buy | 15,000 | 2.42 | 36,300 |
| 2007-10-26 | QLTI | Buy | 39,847 | 4.58 | 182,339 |
| 2007-05-10 | QLTI | Buy | 10,000 | 7.40 | 74,000 |
| 2006-03-10 | QLTI | Buy | 13,500 | 7.31 | 98,685 |
| 2005-08-01 | QLTI | Sale | 7,100 | 8.68 | 61,649 |
| 2005-08-01 | QLTI | Sale | 7,100 | 8.68 | 61,649 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Butchofsky Robert (President and CEO of Novelion Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.